Trial Profile
Change in AV-1451 positron emission tomography imaging in patients with Progressive Supranuclear Palsy and Cortico-Basal Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2017
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Progressive supranuclear palsy
- Focus Diagnostic use
- 16 Jul 2017 New trial record
- 08 Jun 2017 Results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders